LHLianyi Han

Lianyi Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lianyi Han has a total of 189 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MoleculeFormer is a GCN-transformer architecture for molecular property prediction

    by Mingyuan Qin, Ziyan Sun, Lei Feng, Chongyin Han, Jingjing Xia, Lianyi Han

    Artificial intelligence is increasingly important in drug discovery, particularly in molecular property prediction. Graph Neural Networks can model molecular structures as graphs, using structural data to predict molecular properties and biological activities effectively. However, molecular feature optimization and model integration remain challenges. To address these challenges, we propose MoleculeFormer, a multi-scale feature integration model based on Graph Convolutional Network-Transformer architecture. It uses independent Graph Convolutional Network and Transformer modules to extract features from atom and bond graphs while incorporating rotational equivariance constraints and prior molecular fingerprints. The model captures both local and global features and introduces 3D structural information with invariance to rotation and translation. Experiments on 28 datasets show robust performance across various drug discovery tasks, including efficacy/toxicity prediction, phenotype screening, and ADME evaluation. The integration of attention mechanisms enhances interpretability, and the model demonstrates strong noise resistance, establishing MoleculeFormer as an effective, generalizable solution for molecular prediction tasks.


  • Open Access

    PersADE: a database of personalized adverse drug events and their underlying molecular mechanisms

    by Zhuohang Yu, Yimeng Wang, Yintao Zhang, Ying Zhou, Xiaoxiao Hu, Lesang Shen, Chao Ni, Ping Xing, Fengbo Huang, Tingting Fu, et al.

    As a major burden on global healthcare systems, adverse drug events (ADEs) result in significant morbidity, mortality, and healthcare resource consumption. With the rapid advances in precision medicine, personalized ADEs and their molecular mechanisms are important components of drug repurposing and drug safety improvement. Thus, extensive studies have been conducted to collect valuable information on personalized ADEs, but no database has yet been available to provide such data. In this work, PersADE, a database aiming to provide personalized drug adverse events and their molecular mechanisms, was constructed. It integrated 4 061 772 personalized drug-ADE associations, 31 756 protein-ADE associations, and 108 677 drug-protein interactions, with a particular emphasis on off-target effects. The uniqueness of these data lies in (a) providing demographic characteristics, disease context and drug administration parameters associated with ADEs, enabling stratification of drug-ADE associations; (b) systematically integrating interactions among drugs, human proteins and ADEs, describing the mechanistic insights. Given the growing global focus on precision medicine, PersADE is highly anticipated to significantly impact studies on personalized ADEs and mechanistic explorations by providing researchers and clinicians with evidence-based tools. It is now freely accessible at: https://idrblab.org/PersADE


  • Open Access

    Integrative Multi-omics Deciphers the Assembly Rules of the Human Skin Microbiome and Highlights Lipid-Mediated Niche Partitioning

    by Huizhen Chen, Wei Luo, Zhiming Guo, Zhiming Li, Jianju Feng, Shensong Cao, Qi Wang, Zhenglong Gu, Jean Krutmann, Jiucun Wang, et al.

    Understanding the ecological assembly mechanisms of microbial communities is critical for deciphering host-microbiota interactions, however, such processes remain poorly characterized in cutaneous ecosystems. By profiling a non-industrialized rural cohort, this study deciphers the assembly rules governing the human skin microbiome and reveals an evolutionarily conserved core microbiota structured by niche selection. Microbial α-diversity peaks when C. acnes and M. osloensis reach equilibrium, supporting the Intermediate Disturbance Hypothesis. Host lipids, rather than aqueous compounds, emerged as the primary drivers of microbial niche partitioning. We further demonstrate that C. acnes and Malassezia restricta function as core metabolic engineers, expressing diverse lipases that hydrolyze triglycerides (TGs) into free fatty acids (FFAs), thereby maintaining skin surface lipid homeostasis (∼85% TG + FFA). Notably, virtually all skin surface FFAs are microbially derived and function as “public goods”, enabling cross-feeding that supports auxotrophic members and fosters mutualistic interactions. Importantly, in vitro coculture experiments confirm that C. acnes establish a survival niche for M. restricta . Our findings support a paradigm shift from a taxonomic to a functional understanding of the skin ecosystem, underscoring microbial lipid metabolism as a central orchestrator of ecological stability and a promising target for therapeutic intervention. Abstract Figure: GRAPHIC ABSTRACT


  • Open Access

    Microllm: a structured information extraction tool using large language models and named entity recognition in microbiology

    by Jing Lu, Fei Li, Lei Feng, Zhengyu Yu, Jianyu Lu, Mingyuan Qin, Shengnan She, Haoqiang Jiang, Zhiming Guo, Jingjing Xia, et al.

    Understanding the characteristics of individual microorganisms is crucial for deciphering microbial community structures and enabling effective system manipulation. Large-scale analysis in microbial bioinformatics is hindered by the scarcity of high-quality annotated datasets, the labor-intensive, and time-consuming process of manual review, and the limitations of current natural language processing (NLP) technologies in effectively capturing comprehensive information. To tackle these challenges, we developed a new tool MicroLLM, which integrates fine-tuned large language models (LLMs) and bidirectional encoder representations from Transformers (BERT) to enhance the extraction of microbial phenotypic information. MicroLLM converts unstructured text into structured JSON objects, making the data more accessible and organized. By leveraging the strengths of LLMs and named entity recognition (NER), it efficiently extracts complex, multirelational, and multi-entity information. This method establishes a strong foundation for constructing large-scale structured knowledge bases, streamlining the creation of scientific knowledge, and advancing our understanding of microbial ecosystems and their impacts on health.


  • Open Access

    AI dermatology: Reviewing the frontiers of skin cancer detection technologies

    by Zhengyu Yu, Chao Xin, Yingzhe Yu, Jingjing Xia, Lianyi Han


  • Open Access

    Deep Multi-Modal Skin-Imaging-Based Information-Switching Network for Skin Lesion Recognition

    by Yingzhe Yu, Huiqiong Jia, Li Zhang, Suling Xu, Xiaoxia Zhu, Jiucun Wang, Fangfang Wang, Lianyi Han, Haoqiang Jiang, Qiongyan Zhou, et al.

    The rising prevalence of skin lesions places a heavy burden on global health resources and necessitates an early and precise diagnosis for successful treatment. The diagnostic potential of recent multi-modal skin lesion detection algorithms is limited because they ignore dynamic interactions and information sharing across modalities at various feature scales. To address this, we propose a deep learning framework, Multi-Modal Skin-Imaging-based Information-Switching Network (MDSIS-Net), for end-to-end skin lesion recognition. MDSIS-Net extracts intra-modality features using transfer learning in a multi-scale fully shared convolutional neural network and introduces an innovative information-switching module. A cross-attention mechanism dynamically calibrates and integrates features across modalities to improve inter-modality associations and feature representation in this module. MDSIS-Net is tested on clinical disfiguring dermatosis data and the public Derm7pt melanoma dataset. A Visually Intelligent System for Image Analysis (VISIA) captures five modalities: spots, red marks, ultraviolet (UV) spots, porphyrins, and brown spots for disfiguring dermatosis. The model performs better than existing approaches with an mAP of 0.967, accuracy of 0.960, precision of 0.935, recall of 0.960, and f1-score of 0.947. Using clinical and dermoscopic pictures from the Derm7pt dataset, MDSIS-Net outperforms current benchmarks for melanoma, with an mAP of 0.877, accuracy of 0.907, precision of 0.911, recall of 0.815, and f1-score of 0.851. The model’s interpretability is proven by Grad-CAM heatmaps correlating with clinical diagnostic focus areas. In conclusion, our deep multi-modal information-switching model enhances skin lesion identification by capturing relationship features and fine-grained details across multi-modal images, improving both accuracy and interpretability. This work advances clinical decision making and lays a foundation for future developments in skin lesion diagnosis and treatment.


  • Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE ® mobile health study

    by Bernardo Sousa‐Pinto, Aiste Ramanauskaite, Sophia Neisinger, Ellen Witte‐Händel, Ana M. Gimenez‐Arnau, Carole Guillet, Claudio Alberto S. Parisi, Constance H. Katelaris, Daria Fomina, Désirée Larenas‐Linnemann, et al.

    Background: CRUSE® is an app that allows patients with chronic spontaneous urticaria (CSU) to monitor their daily disease activity through the use of visual analogue scales (VASs). We aimed to determine the concurrent validity, reliability, responsiveness and minimal important difference (MID) of CRUSE® VASs. Method s: We evaluated the properties of three daily VASs: VAS for how much patients were affected by their CSU (‘VAS urticaria’), VAS for the impact of urticaria on work/school productivity (‘VAS productivity’) and the VAS of EQ‐5D. Concurrent validity was assessed by measuring the association between each VAS and the Urticaria Activity Score (UAS). Intra‐rater reliability was determined based on the data of users providing multiple daily questionnaires within the same day. Test–retest reliability and responsiveness (ability to change), respectively, were tested in clinically stable and clinically unstable users. MIDs were determined using distribution‐based methods. Results: We included 5938 patients (67,380 days). Concurrent validity was high, with VAS urticaria being more strongly associated with the UAS score than the remaining VASs. Intra‐rater reliability was also high, with intraclass correlation coefficients (ICC) being above 0.950 for all VASs. Moderate‐high test–retest reliability and responsiveness were observed, with reliability ICC being highest for VAS EQ‐5D and responsiveness being highest for VAS urticaria. The MID for VAS urticaria was 17 (out of 100) units, compared to 15 units for VAS productivity and 11 units for VAS EQ‐5D. Conclusion: Daily VASs for CSU available in the CRUSE® app display high concurrent validity and intra‐rater reliability and moderate‐high test–retest reliability and responsiveness.


  • rU-Net, Multi-Scale Feature Fusion and Transfer Learning: Unlocking the Potential of Cuffless Blood Pressure Monitoring With PPG and ECG

    by Jiaming Chen, Xueling Zhou, Lei Feng, Bingo Wing-Kuen Ling, Lianyi Han, Hongtao Zhang

    This study introduces an innovative deep-learning model for cuffless blood pressure estimation using PPG and ECG signals, demonstrating state-of-the-art performance on the largest clean dataset, PulseDB. The rU-Net architecture, a fusion of U-Net and ResNet, enhances both generalization and feature extraction accuracy. Accurate multi-scale feature capture is facilitated by short-time Fourier transform (STFT) time-frequency distributions and multi-head attention mechanisms, allowing data-driven feature selection. The inclusion of demographic parameters as supervisory information further elevates performance. On the calibration-based dataset, our model excels, achieving outstanding accuracy (SBP MAE ± std: 4.49 ± 4.86 mmHg, DBP MAE ± std: 2.69 ± 3.10 mmHg), surpassing AAMI standards and earning a BHS Grade A rating. Addressing the challenge of calibration-free data, we propose a fine-tuning-based transfer learning approach. Remarkably, with only 10% data transfer, our model attains exceptional accuracy (SBP MAE ± std: 4.14 ± 5.01 mmHg, DBP MAE ± std: 2.48 ± 2.93 mmHg). This study sets the stage for the development of highly accurate and reliable wearable cuffless blood pressure monitoring devices.


  • Open Access

    MolBiC: the cell-based landscape illustrating molecular bioactivities

    by Yichao Ge, Mengjie Yang, Xinyuan Yu, Ying Zhou, Yintao Zhang, Minjie Mou, Zhen Chen, Xiuna Sun, Feng Ni, Tingting Fu, et al.

    The measurement of cell-based molecular bioactivity (CMB) is critical for almost every step of drug development. With the booming application of AI in biomedicine, it is essential to have the CMB data to promote the learning of cell-based patterns for guiding modern drug discovery, but no database providing such information has been constructed yet. In this study, we introduce MolBiC, a knowledge base designed to describe valuable data on molecular bioactivity measured within a cellular context. MolBiC features 550 093 experimentally validated CMBs, encompassing 321 086 molecules and 2666 targets across 988 cell lines. Our MolBiC database is unique in describing the valuable data of CMB, which meets the critical demands for CMB-based big data promoting the learning of cell-based molecular/pharmaceutical pattern in drug discovery and development. MolBiC is now freely accessible without any login requirement at: https://idrblab.org/MolBiC/.